Sign in

CIK 0000730272 · Large accelerated filer

REPLIGEN CORP

Sign in to watch
Ticker
RGEN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
042729386
Phone
7814499560
Business address
41 SEYON STREET, BUILDING 1, SUITE 100, WALTHAM, MA, 02453
  1. SC 13G/A Stake Amended Statement of Ownership
  2. SC 13G/A Stake Amended Statement of Ownership
  3. SC 13G/A Stake Amended Statement of Ownership
  4. 4 Insider Changes in Ownership
  5. 4 Insider Changes in Ownership
  6. 10-Q Report Quarterly Report
  7. 8-K Event Results of operations
  8. 4 Insider Changes in Ownership
  9. 4 Insider Changes in Ownership
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations
  12. 8-K Event Material agreement · New debt or obligation · Unregistered share sale · Regulation FD disclosure · Other events
  13. 8-K Event Material agreement · Other events
  14. 4 Insider Changes in Ownership
  15. 424B5 Offering Prospectus
  16. 424B5 Offering Prospectus
  17. FWP Offering Free Writing Prospectus
  18. 305B2 Other 305B2
  19. 424B5 Offering Prospectus
  20. 424B5 Offering Prospectus

Page 26 of 69 · 1,379 filings